Anavex Life Sciences
AVXL
AVXL
135 hedge funds and large institutions have $370M invested in Anavex Life Sciences in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
2.64% less ownership
Funds ownership: 29.85% → 27.21% (-2.6%)
25% less capital invested
Capital invested by funds: $495M → $370M (-$125M)
Holders
135
Holding in Top 10
–
Calls
$19M
Puts
$18.2M
Top Buyers
| 1 | +$6.16M | |
| 2 | +$6.11M | |
| 3 | +$4.96M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.1M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$2.69M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$10.1M | |
| 3 | -$4.07M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.06M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.48M |